Trial intelligence / Profile preview

Oral vs IV Antibiotics in Rectal Cancer Surgery

NCT03436719Unknown

Sponsor
State Scientific Centre of Coloproctology
Start
Nov 2017
Primary completion
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of erythromycin and metronidazole in surgical site infection (SSI) (2 arms), sponsored by State Scientific Centre of Coloproctology. Primary endpoint: Rate of Surgical Site Infection at 30 days. Status: unknown.

02

Drugs

erythromycinmetronidazole
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT03436719.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03436719.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call